Senator Josh Hawley (R-MO) is taking the fight directly to Big Pharma's abortion industry, demanding that President Trump's Justice Department launch a comprehensive investigation into Danco Laboratories, the primary distributor of the controversial abortion drug mifepristone.
In a letter sent Tuesday to acting Attorney General Todd Blanche, Hawley is applying serious pressure on the Trump administration to scrutinize the safety and regulatory oversight of a drug that has been rushed to market with minimal long-term safety data. This comes as the FDA faces its own internal safety review of the chemical abortion pill.
Patriots have long questioned why the medical establishment has been so eager to push chemical abortions while downplaying potential risks to women. Now we're finally seeing real leadership from conservatives willing to ask the hard questions the mainstream media won't touch.
Trump Administration Under Pressure to Act
This isn't just about one senator making noise – it's part of a broader conservative push to hold the abortion industry accountable for putting profits over women's safety. Republican lawmakers and pro-life advocates are demanding answers about how mifepristone received such expedited approval and whether proper safety protocols were followed.
"The American people deserve to know the truth about what Big Pharma and the abortion lobby have been hiding," a source close to the investigation told conservative media outlets.
The timing is crucial. With Trump back in the White House and Republicans controlling the government, there's finally an opportunity to conduct real oversight of an industry that operated with impunity under the Biden regime.
Hawley's move represents exactly the kind of fearless conservative leadership Americans voted for in 2024. While establishment Republicans might shy away from taking on Big Pharma, Hawley is proving once again that he's willing to fight for the values that matter most to everyday Americans.
Will Trump's DOJ have the courage to take on the abortion-pharmaceutical complex? The answer could determine whether this administration truly delivers on its promise to drain the swamp and protect American families.